Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
FASEB J ; 18(14): 1770-2, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15345696

ABSTRACT

Mucus hypersecretion is a hallmark of asthma that contributes to airway obstruction. While the etiology is not well understood, hypersecretion has been linked to the presence of cytokines such as IL-4, IL-5, IL-9, and IL-13 in the inflamed airway. The presence of adenosine has also been noted in asthmatic airways, and adenosine-mediated signaling in mast cells has been implicated in the severe bronchoconstriction and inflammation prevalent in these patients (1, 2). Here we examine the possibility that adenosine also contributes to mucus hypersecretion by airway epithelial cells. Results in cultured airway epithelial cells showed that MUC2 mucin expression increased in response to adenosine. This appeared to be mediated by a pathway initiated at the adenosine A1 receptor that transduced signals through a Ca2+-activated Cl- channel and EGFR. That this signaling cascade is relevant to asthmatic hypersecretion was indicated by results showing that mucin induction by asthmatic tracheal aspirates was reduced by A1, CLCA1, and EGFR inhibitors. These results suggest that adenosine cooperates with inflammatory cytokines to stimulate mucin production in the asthmatic airway and supports the use of A1, CLCA1, and EGFR inhibitors in the treatment of asthma.


Subject(s)
Adenosine/physiology , Asthma/metabolism , Mucins/biosynthesis , Up-Regulation , Adenosine/pharmacology , Asthma/genetics , ErbB Receptors/metabolism , Humans , Ion Channels/antagonists & inhibitors , Mucin-2 , Mucins/genetics , Niflumic Acid/pharmacology , Phosphorylation , Receptors, Purinergic P1/metabolism , Respiratory Mucosa/metabolism , Trachea/metabolism , Transcriptional Activation
2.
Endocrine ; 20(1-2): 101-10, 2003.
Article in English | MEDLINE | ID: mdl-12668874

ABSTRACT

In this study, we have tested the hypothesis that unmodified prolactin (U-PRL) and phosphorylated prolactin (P-PRL) have differential roles in the autoregulation of PRL secretion in vivo. Recombinant human U-PRL and a molecular mimic of P-PRL (S179D PRL) were administered to male rats and to female rats in different physiological states and the effect on rat PRL release was measured. Administration of U-PRL elevated rat PRL in all female animals, but was without effect in males. By contrast, S179D PRL was inactive in females, but inhibited PRL release in males. Morphometric and immunohistochemical analyses demonstrated acidophil hypertrophy and evidence of increased PRL secretion in the pituitaries of U-PRL-treated females. Analysis of the two forms of PRL during prolactinoma induction in two differentially susceptible strains of rats found a strong temporal correlation among increased ratios of U-PRL: P-PRL, increased circulating PRL, and increased cell proliferation. We conclude (1). that the autoregulatory mechanism(s) can distinguish between the two major forms of PRL and that higher proportions of U-PRL not only allow for higher circulating levels of PRL, but are also autostimulatory, (2). that the autoregulatory mechanism( s) are set differently in males and females such that females are more sensitive to autostimulation by U-PRL and less sensitive to inhibition by P-PRL, and (3). that U-PRL and P-PRL may also have differential roles in the regulation of pituitary cell proliferation.


Subject(s)
Adenoma, Acidophil/metabolism , Pituitary Neoplasms/metabolism , Prolactin/metabolism , Prolactin/pharmacology , Adenoma, Acidophil/pathology , Animals , Cell Division/drug effects , Estradiol/pharmacology , Female , Hyperplasia , Hyperprolactinemia/metabolism , Hyperprolactinemia/pathology , Hypertrophy , Male , Molecular Mimicry , Pituitary Neoplasms/pathology , Pregnancy , Prolactin/chemistry , Rats , Rats, Inbred F344 , Rats, Sprague-Dawley
3.
Prostate ; 54(1): 25-33, 2003 Jan 01.
Article in English | MEDLINE | ID: mdl-12481252

ABSTRACT

BACKGROUND: In the current study, we have investigated the individual roles of unmodified, wild-type prolactin (WT PRL) and a molecular mimic of phosphorylated prolactin (S179D PRL) in the normal rat prostate. METHODS: In the first animal experiment, recombinant WT PRL and S179D PRL were delivered to adult male rats at a rate of 14 microg/kg per day for 3 weeks. In the second animal experiment, two subcutaneous (200 microg/kg) injections of long-acting forms of the two PRLs were given to adult male rats on day 1 and day 22 for a total of 5.5 weeks of treatment. RESULTS: The different forms of PRL had opposite effects on the normal rat prostate, independently of androgens. WT PRL promoted morphologic changes in prostate epithelium consistent with preparation for cell proliferation, whereas S179D PRL produced morphologic evidence of a more differentiated epithelium. Northern blot analysis of expression of the two major prostate specific proteins, prostatein and probasin, showed that WT PRL decreased, whereas S179D PRL increased, the expression of the mRNAs for these two proteins. At the same time, S179D PRL reduced both testosterone and dihydrotestosterone levels. CONCLUSION: We conclude that PRL is an important modulator of normal rat prostate biology and that different forms of PRL have specific functions. The molecular mimic of phosphorylated PRL, S179D PRL, is the most important in terms of epithelial cell differentiation.


Subject(s)
Cell Differentiation/physiology , Cell Division/physiology , Gene Expression Regulation , Prolactin/pharmacology , Prostate/cytology , Prostate/physiology , Animals , DNA Primers , Dihydrotestosterone/analysis , Male , Phosphorylation , Prolactin/analogs & derivatives , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Testosterone/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...